スマートピル市場の分析と予測：用途、対象部位、適応症、エンドユーザー別 2018年〜2025年

世界のスマートピル市場は、2017年に2億5,700万米ドルと評価され、2018年から2025年にかけては12.1%のCAGRで推移し、6億5,000万米ドル規模の市場に成長することが予測されています。

当レポートでは、世界のスマートピル市場を調査し、市場の概要、用途・対象部位・適応症・エンドユーザー・地域別の市場規模の推移と予測、市場動向、市場の成長要因と阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

• レポートの説明
• ステークホルダーの主な利点
• 主要な市場セグメント
• 調査方法

第2章 エグゼクティブサマリー

第3章 市場の概観

• 市場の定義と範囲
• 主な所見
• ファイブフォース分析
• 市場シェア分析
• 市場力学
  • 成長要因
  • 阻害要因
  • 市場機会

第4章 スマートピル市場：用途別

• 概要
  • 市場規模と予測
• カプセル内視鏡
  • 主な傾向と機会
  • 市場規模と予測
  • 市場分析：国別
• ドラッグデリバリー
• 患者モニタリング

第5章 スマートピルの市場：対象部位別

• 概要
  • 市場規模と予測
• 食道
  • 市場規模と予測
  • 市場分析：国別
• 胃
• 小腸
• 大腸

第6章 スマートピル市場：適応症別

• 概要
  • 市場規模と予測
• 食道疾患
  • 市場規模と予測
  • 市場分析：国別
• 小腸疾患
• 大腸疾患

第7章 スマートピル市場：エンドユーザー別

• 概要
  • 市場規模と予測
• 診断センター
  • 市場規模と予測
  • 市場分析：国別
• 病院・診療所
• 研究機関

第8章 スマートピル市場：地域別

• 概要
  • 市場規模と予測
• 北米
  • 市場規模と予測：国別
  • 市場規模と予測：セグメント別
• 欧州
• アジア太平洋地域
• ラテンアメリカ・中東・アフリカ

第9章 企業プロファイル

• CapsoVision, Inc.
• Check-Cap Ltd.
• HQ.Inc.
• IntroMedic Co., Ltd
• JINSHAN Science & Technology
• Koninklijke Philips N.V.
• Medtronic plc
• オリンパス
• Proteus Digital Health
• RF Co., Ltd.

List of Tables

• TABLE 01. GLOBAL SMART PILLS MARKET, BY APPLICATION 20172025 ($MILLION)
• TABLE 02. CAPSULE ENDOSCOPE AVAILABLE IN THE MARKET
• TABLE 03. GLOBAL SMART PILLS MARKET FOR CAPSULE ENDOSCOPY, BY REGION, 20172025 ($MILLION)
• TABLE 04. SMART CAPSULE FOR DRUG DELIVERY AVAILABLE IN THE MARKET
• TABLE 05. SMART PILLS MARKET FOR DRUG DELIVERY, BY REGION, 20172025 ($MILLION)
• TABLE 06. SMART CAPSULE FOR PATIENT MONITORING AVAILABLE IN THE MARKET
• TABLE 07. SMART PILLS MARKET FOR PATIENT MONITORING, BY REGION, 20172025 ($MILLION)
• TABLE 08. GLOBAL SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 09. SMART PILLS MARKET, FOR ESOPHAGUS, BY REGION, 20172025 ($MILLION)
• TABLE 10. SMART PILLS MARKET, FOR STOMACH, BY REGION, 20172025 ($MILLION)
• TABLE 11. SMART PILLS MARKET, FOR SMALL INTESTINE, BY REGION, 20172025 ($MILLION)
• TABLE 12. SMART PILLS MARKET, FOR LARGE INTESTINE, BY REGION, 20172025 ($MILLION)
• TABLE 13. GLOBAL SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 14. SMART PILLS MARKET, FOR ESOPHAGUS DISEASES, BY REGION, 20172025 ($MILLION)
• TABLE 15. SMART PILL MARKET, FOR SMALL BOWEL DISEASES, BY REGION, 20172025 ($MILLION)
• TABLE 16. SMART PILL MARKET, FOR COLON DISEASES, BY REGION, 20172025 ($MILLION)
• TABLE 17. GLOBAL SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 18. SMART PILLS MARKET FOR DIAGNOSTIC CENTRES, BY REGION, 20172025 ($MILLION)
• TABLE 19. GLOBAL SMART PILLS MARKET FOR HOSPITALS, BY REGION, 20172025 ($MILLION)
• TABLE 20. SMART PILLS MARKET FOR RESEARCH INSTITUTES, BY REGION, 20172025 ($MILLION)
• TABLE 21. SMART PILLS MARKET, BY REGION, 20172025 ($MILLION)
• TABLE 22. NORTH AMERICA SMART PILLS MARKET, BY COUNTRY, 20172025 ($MILLION)
• TABLE 23. NORTH AMERICA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 24. NORTH AMERICA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 25. NORTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 26. NORTH AMERICA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 27. U.S. SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 28. U.S. SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 29. U.S. SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 30. U.S. SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 31. CANADA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 32. CANADA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 33. CANADA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 34. CANADA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 35. MEXICO SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 36. MEXICO SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 37. MEXICO SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 38. MEXICO SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 39. EUROPE SMART PILLS MARKET, BY COUNTRY, 20172025 ($MILLION)
• TABLE 40. EUROPE SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 41. EUROPE SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 42. EUROPE SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 43. EUROPE SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 44. GERMANY SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 45. GERMANY SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 46. GERMANY SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 47. GERMANY SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 48. FRANCE SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 49. FRANCE SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 50. FRANCE SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 51. FRANCE SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 52. UK SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 53. UK SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 54. UK SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 55. UK SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 56. ITALY SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 57. ITALY SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 58. ITALY SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 59. ITALY SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 60. SPAIN SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 61. SPAIN SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 62. SPAIN SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 63. SPAIN SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 64. REST OF EUROPE SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 65. REST OF EUROPE SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 66. REST OF EUROPE SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 67. REST OF EUROPE SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 68. ASIA-PACIFIC SMART PILLS MARKET, BY COUNTRY, 20172025 ($MILLION)
• TABLE 69. ASIA-PACIFIC SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 70. ASIA-PACIFIC SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 71. ASIA-PACIFIC SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 72. ASIA-PACIFIC SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 73. INDIA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 74. INDIA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 75. INDIA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 76. INDIA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 77. CHINA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 78. CHINA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 79. CHINA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 80. CHINA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 81. JAPAN SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 82. JAPAN SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 83. JAPAN SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 84. INDIA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 85. AUSTRALIA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 86. AUSTRALIA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 87. AUSTRALIA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 88. AUSTRALIA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 89. REST OF ASIA-PACIFIC SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 90. REST OF ASIA-PACIFIC SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 91. REST OF ASIA-PACIFIC SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 92. REST OF ASIA-PACIFIC SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 93. LAMEA SMART PILLS MARKET, BY COUNTRY, 20172025 ($MILLION)
• TABLE 94. LAMEA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 95. LAMEA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 96. LAMEA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 97. LAMEA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 98. BRAZIL SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 99. BRAZIL SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 100. BRAZIL SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 101. BRAZIL SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 102. SOUTH AFRICA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 103. SOUTH AFRICA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 104. SOUTH AFRICA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 105. SOUTH AFRICA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 106. SAUDI ARABIA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 107. SAUDI ARABIA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 108. SAUDI ARABIA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 109. SAUDI ARABIA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 110. ARGENTINA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 111. ARGENTINA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 112. ARGENTINA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 113. ARGENTINA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 114. REST OF LAMEA SMART PILLS MARKET, BY APPLICATION, 20172025 ($MILLION)
• TABLE 115. REST OF LAMEA SMART PILLS MARKET, BY TARGET AREA, 20172025 ($MILLION)
• TABLE 116. REST OF LAMEA SMART PILLS MARKET, BY DISEASE INDICATION, 20172025 ($MILLION)
• TABLE 117. REST OF LAMEA SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
• TABLE 118. CAPSOVISION: COMPANY SNAPSHOT
• TABLE 119. CAPSOVISION: OPERATING SEGMENTS
• TABLE 120. CAPSOVISION: PRODUCT PORTFOLIO
• TABLE 121. CHECK- CAP: COMPANY SNAPSHOT
• TABLE 122. CHECK-CAP OPERATING SEGMENTS
• TABLE 123. CHECK-CAP PRODUCT PORTFOLIO
• TABLE 124. HQ. COMPANY SNAPSHOT
• TABLE 125. HQ.: OPERATING SEGMENTS
• TABLE 126. HQ.: PRODUCT PORTFOLIO
• TABLE 127. INTROMEDIC: COMPANY SNAPSHOT
• TABLE 128. INTROMEDIC: PRODUCT PORTFOLIO
• TABLE 129. JINSHAN: COMPANY SNAPSHOT
• TABLE 130. JINSHAN: PRODUCT SEGMENTS
• TABLE 131. JINSHAN: PRODUCT PORTFOLIO
• TABLE 132. PHILIPS: COMPANY SNAPSHOT
• TABLE 133. PHILIPS: OPERATING SEGMENTS
• TABLE 134. PHILIPS: PRODUCT PORTFOLIO
• TABLE 135. MEDTRONIC: COMPANY SNAPSHOT
• TABLE 136. MEDTRONIC: OPERATING SEGMENTS
• TABLE 137. MEDTRONIC: PRODUCT PORTFOLIO
• TABLE 138. OLYMPUS: COMPANY SNAPSHOT
• TABLE 139. OLYMPUS: OPERATING SEGMENTS
• TABLE 140. OLYMPUS: PRODUCT PORTFOLIO
• TABLE 141. PROTEUS: COMPANY SNAPSHOT
• TABLE 142. PROTEUS: OPERATING SEGMENTS
• TABLE 143. PROTEUS: PRODUCT PORTFOLIO
• TABLE 144. RF CO., LTD: COMPANY SNAPSHOT
• TABLE 145. RF : PRODUCT SEGMENTS
• TABLE 146. RF CO.: PRODUCT PORTFOLIO

List of Figures

• FIGURE 01. SMART PILLS MARKET SEGMENTATION
• FIGURE 02. TOP INVESTMENT POCKETS IN SMART PILLS MARKET, 2017
• FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2016-2018*
• FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2018* (%)
• FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2016-2018*
• FIGURE 06. HIGH BARGAINING POWER OF SUPPLIERS
• FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
• FIGURE 08. LOW THREAT OF SUBSTITUTION
• FIGURE 09. HIGH THREAT OF NEW ENTRANT
• FIGURE 10. HIGH COMPETITIVE RIVALRY
• FIGURE 11. MARKET SHARE ANALYSIS, 2017
• FIGURE 12. GLOBAL SMART PILLS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
• FIGURE 13. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR CAPSULE ENDOSCOPY, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR DISPOSABLES & REAGENTS, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR PATIENT MONITORING, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR ESOPHAGUS BY COUNTRY, 2017 & 2025 (%)
• FIGURE 17. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR STOMACH, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 18. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR SMALL INTESTINE, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 19. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR LARGE INTESTINE, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 20. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR ESOPHAGUS DISEASES, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 21. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR SMALL BOWEL DISEASES, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 22. GLOBAL SMART PILLS MARKET FOR CROHNS DISEASE, 20172025 ($MILLION)
• FIGURE 23. GLOBAL SMART PILLS MARKET FOR SMALL BOWEL TUMORS, 20172025 ($MILLION)
• FIGURE 24. GLOBAL SMART PILLS MARKET FOR CELIAC DISEASE, 20172025 ($MILLION)
• FIGURE 25. GLOBAL SMART PILLS MARKET FOR CELIAC DISEASE, 20172025 ($MILLION)
• FIGURE 26. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR COLON DISEASES, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 27. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR DIAGNOSTIC CENTRES, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 28. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 29. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025 (%)
• FIGURE 30. INTROMEDIC, 20152017 ($MILLION)
• FIGURE 31. PHILIPS: NET SALES, 20152017 ($MILLION)
• FIGURE 32. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
• FIGURE 33. PHILIPS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
• FIGURE 34. MEDTRONIC, 20152017 ($MILLION)
• FIGURE 35. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
• FIGURE 36. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
• FIGURE 37. OLYMPUS: REVENUE, 20152017 ($MILLION)
• FIGURE 38. OLYMPUS: REVENUE SHARE BY SEGMENT, 2017 (%)
• FIGURE 39. OLYMPUS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

Title:
Smart Pills Market by Application (Capsule Endoscopy, Patient Monitoring, and Drug Delivery), Target Area (Stomach, Esophagus, Small Intestine, and Large Intestine), Disease Indication (Esophageal Diseases, Small bowel Diseases, Colon Diseases, and Others), and End User (Hospital, Diagnostic Center, and Research Center): Global Opportunity Analysis and Industry Forecast, 2018 - 2025 .

Smart Pills Market Overview:

The global smart pills market was valued at $257 million in 2017, and is expected to reach $650 million by 2025, registering a CAGR of 12.1% from 2018 to 2025. Smart pill is an ingestible capsule with miniaturized micro-electronics. Smart pill is designed to visualize the gastrointestinal tract, thus allowing for the diagnosis and observation of lesions and disease states or conditions. As the capsule travels through the digestive tract, the camera clicks thousands of pictures that are transmitted to a recorder worn by the patient on a belt around the waist. Smart pills are widely being used for the diagnosis of various gastrointestinal disorders such as Barrett's Esophagus, Irritable Bowel Syndrome, GERD (Gastroesophageal reflux disease) and others. In addition, smart pills are also being used for targeted drug delivery and patient monitoring. Smart pills find applications in solving the problem of medication non-adherence and enables the doctor to track the medication consumption patterns of a patient.

The key factors driving the market growth include rise in prevalence of gastrointestinal disorders such as ulcers, Crohn's disease, colon cancer and others, favorable reimbursement scenario across the globe, and the preference of a patient toward minimally invasive diagnostic procedures. In addition, benefits offered by the smart pills such as non-invasive diagnostic procedures, controlled/targeted drug delivery, and real-time patient monitoring boost the growth of the market. However, stringent governmental regulations regarding the use of smart pills and high cost associated with them are anticipated to hamper the market growth. On the contrary, technological advancements, such as microprocessors, micro-camera, micro-sensors, and others, are predicted to create lucrative opportunities in the future.

The global smart pills market is segmented based on application, target area, disease indication, end user, and region. Based on application, the market is divided into capsule endoscopy, drug delivery, and patient monitoring. Based on target area, the market is classified into esophagus, small intestine, large intestine, and stomach. Based on disease indication, it is classified into Barrett's esophagus, Crohn's disease, small bowel tumor, celiac disease, colon cancer, and others. Based on end user, it is classified into hospital, diagnostic center, and research center. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Smart Pills Market:

• The study provides an in-depth analysis of the smart pills market with the current trends and future estimations to elucidate the imminent investment pockets.

• A comprehensive analysis of the factors that drive and restrict the market growth is provided.

• A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

• An extensive analysis of the key segments of the industry helps to understand the trends in the smart pills market globally.

• Key players and their strategies are provided to understand the competitive outlook of the industry.

Smart Pills Key Market Segments:

By Application

• Capsule Endoscopy
• Drug Delivery
• Patient Monitoring

By Target Area

• Esophagus
• Small Intestine
• Large Intestine
• Stomach

By Disease Indication

• Esophageal Diseases
• Small Bowel Diseases
• Colon Diseases
• Others

By End User

• Hospital
• Diagnostic Center
• Research Institute

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • UK
  • France
  • Germany
  • Italy
  • France
  • Russia
  • Rest of Europe

• Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Australia
  • Rest of Asia-Pacific

• LAMEA
  • Saudi Arabia
  • South Africa
  • Brazil
  • Turkey
  • Argentina
  • Rest of LAMEA

KEY MARKET PLAYERS:

• Proteus Digital Health
• HQ, Inc.
• CapsoVision, Inc.
• Medtronic Plc.
• Olympus Corporations
• IntroMedic Co., Ltd
• RF Co., Ltd
• JINSHAN Science & Technology
• Check Cap
• Koninklijke Philips N.V

The other players in the value chain include:

(profiles not included in the report)

• GE Healthcare
• NOVARTIS AG
• Fujifilm Holdings Corporation
• Bio-Images Drug Delivery (BDD) Limited
• Quotient Clinical Ltd.
• Innovative Devices LLC
• PENTAX Medical

Table of Contents

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key benefits for stakeholders
• 1.3. Key market segments
• 1.4. Research methodology
• 1.4.1. Secondary research
• 1.4.2. Primary research
• 1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
• 3.2.1. Top investment pockets
• 3.2.2. Top Winning Strategies
• 3.3. Porters five forces analysis
• 3.4. Market share analysis
• 3.5. Market dynamics
• 3.5.1. Drivers
• 3.5.1.1. Rising prevalence of gastrointestinal disorders
• 3.5.1.2. Increase in the R&D investments in developing smart pills by manufacturers
• 3.5.2. Restraints
• 3.5.2.1. Lengthy timelines regarding approval of smart pills
• 3.5.2.2. Higher costs associated with the smart pills
• 3.5.3. Opportunity
• 3.5.3.1. Increase in the technological advancements pertaining to smart pills

CHAPTER 4: SMART PILLS MARKET, BY APPLICATION

• 4.1. Overview
• 4.1.1. Market size and forecast
• 4.2. Capsule Endoscopy
• 4.2.1. Key trends and opportunities
• 4.2.2. Market size and forecast
• 4.2.3. Market analysis, by country
• 4.3. Drug Delivery
• 4.3.1. Key trends and opportunities
• 4.3.2. Market size and forecast
• 4.3.3. Market analysis, by country
• 4.4. Patient Monitoring
• 4.4.1. Key trends and opportunities
• 4.4.2. Market size and forecast
• 4.4.3. Market analysis, by country

CHAPTER 5: SMART PILLS MARKET, BY TARGET AREA

• 5.1. Overview
• 5.1.1. Market size and forecast
• 5.2. Esophagus
• 5.2.1. Market size and forecast
• 5.2.2. Market analysis, by country
• 5.3. Stomach
• 5.3.1. Market size and forecast
• 5.3.2. Market analysis, by country
• 5.4. Small Intestine
• 5.4.1. Market size and forecast
• 5.4.2. Market analysis, by country
• 5.5. Large Intestine
• 5.5.1. Market size and forecast
• 5.5.2. Market analysis, by country

CHAPTER 6: SMART PILLS MARKET, BY DISEASE INDICATION

• 6.1. Overview
• 6.1.1. Market size and forecast
• 6.2. Esophagus Diseases
• 6.2.1. Market size and forecast
• 6.2.2. Market analysis, by country
• 6.3. Small Bowel Disease
• 6.3.1. Market size and forecast
• 6.3.2. Market analysis, by country
• 6.3.2.1. Crohns Disease
• 6.3.2.1.1. Market size and forecast
• 6.3.2.2. Small bowel tumors
• 6.3.2.2.1. Market size and forecast
• 6.3.2.3. Celiac disease
• 6.3.2.3.1. Market size and forecast
• 6.3.2.4. Others
• 6.3.2.4.1. Market size and forecast
• 6.4. Colon Diseases
• 6.4.1. Market size and forecast
• 6.4.2. Market analysis, by country

CHAPTER 7: SMART PILLS MARKET, BY END USER

• 7.1. Overview
• 7.1.1. Market size and forecast
• 7.2. Diagnostic Centers
• 7.2.1. Market size and forecast
• 7.2.2. Market analysis, by country
• 7.3. Hospitals & Clinics
• 7.3.1. Market size and forecast
• 7.3.2. Market analysis, by country
• 7.4. Research Institutes
• 7.4.1. Market size and forecast
• 7.4.2. Market analysis, by country

CHAPTER 8: SMART PILLS MARKET, BY REGION

• 8.1. Overview
• 8.1.1. Market size and forecast
• 8.2. North America
• 8.2.1. North America market size & forecast, by country
• 8.2.2. North America market size & forecast, by application
• 8.2.3. North America market size & forecast, by target area
• 8.2.4. North America market size & forecast, by disease indication
• 8.2.5. North America market size & forecast, by end user
• 8.2.5.1. U.S. market size & forecast, by application
• 8.2.5.2. U.S. market size & forecast, by target area
• 8.2.5.3. U.S. market size & forecast, by disease indication
• 8.2.5.4. U.S. market size & forecast, by end user
• 8.2.5.5. Canada market size & forecast, by application
• 8.2.5.6. Canada market size & forecast, by target area
• 8.2.5.7. Canada market size & forecast, by disease indication
• 8.2.5.8. Canada market size & forecast, by end user
• 8.2.5.9. Mexico market size & forecast, by application
• 8.2.5.10. Mexico market size & forecast, by target area
• 8.2.5.11. Mexico market size & forecast, by disease indication
• 8.2.5.12. Mexico market size & forecast, by end user
• 8.3. Europe
• 8.3.1. Key trends and opportunities
• 8.3.2. Europe market size & forecast for smart pills market, by country
• 8.3.3. Europe market size & forecast, by application
• 8.3.4. Europe market size & forecast, by target area
• 8.3.5. Europe market size & forecast, by disease indication
• 8.3.6. Europe market size & forecast, by end user
• 8.3.6.1. Germany market size & forecast, by application
• 8.3.6.2. Germany market size & forecast, by target area
• 8.3.6.3. Germany market size & forecast, by disease indication
• 8.3.6.4. Germany market size & forecast, by end user
• 8.3.6.5. France market size & forecast, by application
• 8.3.6.6. France market size & forecast, by target area
• 8.3.6.7. France market size & forecast, by disease indication
• 8.3.6.8. France market size & forecast, by end user
• 8.3.6.9. UK market size & forecast, by application
• 8.3.6.10. UK market size & forecast, by target area
• 8.3.6.11. UK market size & forecast, by disease indication
• 8.3.6.12. UK market size & forecast, by end user
• 8.3.6.13. Italy market size & forecast, by application
• 8.3.6.14. Italy market size & forecast, by target area
• 8.3.6.15. Italy market size & forecast, by disease indication
• 8.3.6.16. Italy market size & forecast, by end user
• 8.3.6.17. Spain market size & forecast, by application
• 8.3.6.18. Spain market size & forecast, by target area
• 8.3.6.19. Spain market size & forecast, by disease indication
• 8.3.6.20. Spain market size & forecast, by end user
• 8.3.6.21. Rest of Europe market size & forecast, by application
• 8.3.6.22. Rest of Europe market size & forecast, by target area
• 8.3.6.23. Rest of Europe market size & forecast, by disease indication
• 8.3.6.24. Rest of Europe market size & forecast, by end user
• 8.4. Asia-Pacific
• 8.4.1. Key trends and opportunities
• 8.4.2. Asia-Pacific market size & forecast, by country
• 8.4.3. Asia-Pacific market size & forecast, by application
• 8.4.4. Asia-Pacific market size & forecast, by target area
• 8.4.5. Asia-Pacific market size & forecast, by disease indication
• 8.4.6. Asia-Pacific market size & forecast, by end user
• 8.4.6.1. India market size & forecast, by application
• 8.4.6.2. India market size & forecast, by target area
• 8.4.6.3. India market size & forecast, by disease indication
• 8.4.6.4. India market size & forecast, by end user
• 8.4.6.5. China market size & forecast, by application
• 8.4.6.6. China market size & forecast, by target area
• 8.4.6.7. China market size & forecast, by disease indication
• 8.4.6.8. China market size & forecast, by end user
• 8.4.6.9. Japan market size & forecast, by application
• 8.4.6.10. Japan market size & forecast, by target area
• 8.4.6.11. Japan market size & forecast, by disease indication
• 8.4.6.12. India market size & forecast, by end user
• 8.4.6.13. Australia market size & forecast, by application
• 8.4.6.14. Australia market size & forecast, by target area
• 8.4.6.15. Australia market size & forecast, by disease indication
• 8.4.6.16. Australia market size & forecast, by end user
• 8.4.6.17. Rest of Asia-Pacific market size & forecast, by application
• 8.4.6.18. Rest of Asia-Pacific market size & forecast, by Target Area
• 8.4.6.19. Rest of Asia-Pacific market size & forecast, by disease indication
• 8.4.6.20. Rest of Asia-Pacific market size & forecast, by end user
• 8.5. LAMEA
• 8.5.1. Key trends and opportunities
• 8.5.2. LAMEA market size & forecast, by country
• 8.5.3. LAMEA market size & forecast, by application
• 8.5.4. LAMEA market size & forecast, by target area
• 8.5.5. LAMEA market size & forecast, by disease indication
• 8.5.6. LAMEA market size & forecast, by end user
• 8.5.6.1. Brazil market size & forecast, by application
• 8.5.6.2. Brazil market size & forecast, by target area
• 8.5.6.3. Brazil market size & forecast, by disease indication
• 8.5.6.4. Brazil market size & forecast, by end user
• 8.5.6.5. South Africa market size & forecast, by application
• 8.5.6.6. South Africa market size & forecast, by target area
• 8.5.6.7. South Africa market size & forecast, by disease indication
• 8.5.6.8. South Africa market size & forecast, by end user
• 8.5.6.9. Saudi Arabia market size & forecast, by application
• 8.5.6.10. Saudi Arabia market size & forecast, by target area
• 8.5.6.11. Saudi Arabia market size & forecast, by disease indication
• 8.5.6.12. Saudi Arabia market size & forecast, by end user
• 8.5.6.13. Argentina market size & forecast, by application
• 8.5.6.14. Argentina market size & forecast, by target area
• 8.5.6.15. Argentina market size & forecast, by disease indication
• 8.5.6.16. Argentina market size & forecast, by end user
• 8.5.6.17. Rest of LAMEA market size & forecast, by application
• 8.5.6.18. Rest of LAMEA market size & forecast, by target area
• 8.5.6.19. Rest of LAMEA market size & forecast, by disease indication
• 8.5.6.20. Rest of LAMEA market size & forecast, by end user

CHAPTER 9: COMPANY PROFILES

• 9.1. CapsoVision, Inc.
• 9.1.1. Company overview
• 9.1.2. Company snapshot
• 9.1.3. Operating business segments
• 9.1.4. Product portfolio
• 9.1.5. Key strategic moves and developments
• 9.2. Check-Cap Ltd.
• 9.2.1. Company overview
• 9.2.2. Company snapshot
• 9.2.3. Operating business segments
• 9.2.4. Product portfolio
• 9.3. HQ.Inc.
• 9.3.1. Company overview
• 9.3.2. Company snapshot
• 9.3.3. Operating business segments
• 9.3.4. Product portfolio
• 9.4. IntroMedic Co., Ltd
• 9.4.1. Company overview
• 9.4.2. Company snapshot
• 9.4.3. Operating business segments
• 9.4.4. Product portfolio
• 9.4.5. Business performance
• 9.4.6. Key strategic moves and developments
• 9.5. JINSHAN Science & Technology
• 9.5.1. Company overview
• 9.5.2. Company snapshot
• 9.5.3. Operating business segments
• 9.5.4. Product portfolio
• 9.5.5. Key strategic moves and developments
• 9.6. Koninklijke Philips N.V.
• 9.6.1. Company overview
• 9.6.2. Company snapshot
• 9.6.3. Operating business segments
• 9.6.4. Product portfolio
• 9.6.5. Business performance
• 9.7. Medtronic plc
• 9.7.1. Company overview
• 9.7.2. Company snapshot
• 9.7.3. Operating business segments
• 9.7.4. Product portfolio
• 9.7.5. Business performance
• 9.7.6. Key strategic moves and developments
• 9.8. OLYMPUS Corporation.
• 9.8.1. Company overview
• 9.8.2. Company snapshot
• 9.8.3. Operating business segments
• 9.8.4. Product portfolio
• 9.8.5. Business performance
• 9.9. Proteus Digital Health
• 9.9.1. Company overview
• 9.9.2. Company snapshot
• 9.9.3. Operating business segments
• 9.9.4. Product portfolio
• 9.9.5. Key strategic moves and developments
• 9.10. RF Co., Ltd.
• 9.10.1. Company overview
• 9.10.2. Company snapshot
• 9.10.3. Operating business segments
• 9.10.4. Product portfolio